title: Update on immunohistochemistry in melanocytic lesions.
abstract: This article is an up-to-date overview of the potential uses and limitations of immunohistochemistry (IHC) in melanocytic lesions. The information is intended to assist dermatopathologists and dermatologists who read slides to appropriately use IHC in this setting. In addition, dermatologists who do not review microscopic slides will better understand the rationale of the pathologist when reading and interpreting the pathology report.
authors.affiliation: Department of Dermatology, Geisinger Medical Center, Danville, PA 17822, USA. tferringer@geisinger.edu
authors.forename: Tammie
authors.initials: T
authors.lastname: Ferringer
mesh_terms: D000951:Antigens, Neoplasm / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000276:immunology*; D006801:Humans; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis; D008544:Melanocytes / Q000276:immunology / Q000473:pathology; D008545:Melanoma / Q000276:immunology* / Q000556:secondary; D009508:Nevus, Pigmented / Q000276:immunology* / Q000473:pathology; D012878:Skin Neoplasms / Q000276:immunology* / Q000473:pathology*
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor